| Hypersensitivity to the drug or its components. Patients receiving opioid analgesics or currently dependent on opioids, acute opioid withdrawal symptoms, those who has failed the Naloxone challenge test or having positive urine screen for opioids and in cases of severe hepatic and renal impairment. |